Answers are grounded in this paper and cite their sources.
We have proposed methods for defining and applying benchmarks for ADR in average-risk patients that go beyond the "minimally acceptable" threshold currently recommended.
No takes yet. Share an insight, caveat, or question.
Hilsden et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: